For: | Sun YN, Luo JY. Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord. World J Gastroenterol 2004; 10(12): 1830-1833 [PMID: 15188517 DOI: 10.3748/wjg.v10.i12.1830] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i12/1830.htm |
Number | Citing Articles |
1 |
D. T. Beattie, J. A. M. Smith. Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn-Schmiedeberg's Archives of Pharmacology 2008; 377(3): 181 doi: 10.1007/s00210-008-0276-9
|
2 |
B. Greenwood‐van Meerveld. Importance of 5‐hydroxytryptamine receptors on intestinal afferents in the regulation of visceral sensitivity. Neurogastroenterology & Motility 2007; 19(s2): 13 doi: 10.1111/j.1365-2982.2007.00964.x
|
3 |
Brian E. Lacy, Mark Pimentel, Darren M. Brenner, William D. Chey, Laurie A. Keefer, Millie D. Long, Baha Moshiree. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology 2021; 116(1): 17 doi: 10.14309/ajg.0000000000001036
|
4 |
Emily V. Wechsler, Eric D. Shah. Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment Options. Drugs 2021; 81(17): 1953 doi: 10.1007/s40265-021-01634-7
|
5 |
Kumiko Ishikawa, Yasuhiro Kajiwara, Junya Sakamoto, Ryo Sasaki, Kyo Goto, Yuichiro Honda, Hideki Kataoka, Minoru Okita. Low-intensity muscle contraction exercise following the onset of arthritis improves hyperalgesia via reduction of joint inflammation and central sensitization in the spinal cord in a rat model. Neuroscience Letters 2019; 706: 18 doi: 10.1016/j.neulet.2019.04.031
|
6 |
Olga A. Lyubashina, Ivan B. Sivachenko, Alexey Y. Sokolov. Differential responses of neurons in the rat caudal ventrolateral medulla to visceral and somatic noxious stimuli and their alterations in colitis. Brain Research Bulletin 2019; 152: 299 doi: 10.1016/j.brainresbull.2019.07.030
|
7 |
Kristen E. Farrell, Robert J. Callister, Simon Keely. Understanding and targeting centrally mediated visceral pain in inflammatory bowel disease. Frontiers in Pharmacology 2014; 5 doi: 10.3389/fphar.2014.00027
|
8 |
Kristen E. Farrell, Simon Keely, Marjorie M. Walker, Alan M. Brichta, Brett A. Graham, Robert J. Callister. Altered intrinsic and synaptic properties of lumbosacral dorsal horn neurons in a mouse model of colitis. Neuroscience 2017; 362: 152 doi: 10.1016/j.neuroscience.2017.08.029
|
9 |
B. Greenwood‐van Meerveld, K. Venkova, G. Hicks, E. Dennis, M. D. Crowell. Activation of peripheral 5‐HT4 receptors attenuates colonic sensitivity to intraluminal distension. Neurogastroenterology & Motility 2006; 18(1): 76 doi: 10.1111/j.1365-2982.2005.00723.x
|
10 |
Olga A. Lyubashina, Ivan B. Sivachenko, Sergey S. Panteleev. Supraspinal Mechanisms of Intestinal Hypersensitivity. Cellular and Molecular Neurobiology 2022; 42(2): 389 doi: 10.1007/s10571-020-00967-3
|
11 |
O. A. Lyubashina, I. B. Sivachenko, I. I. Busygina. Features of the Neurophysiological Mechanisms of Visceral and Somatic Pain. Neuroscience and Behavioral Physiology 2023; 53(2): 279 doi: 10.1007/s11055-023-01418-4
|
12 |
Robert D. Foreman. Mechanisms of visceral pain: from nociception to targets. Drug Discovery Today: Disease Mechanisms 2004; 1(4): 457 doi: 10.1016/j.ddmec.2004.11.022
|
13 |
Kwong M Fock, Amy Wagner. Safety, tolerability and satisfaction with tegaserod therapy in Asia–Pacific patients with irritable bowel syndrome with constipation. Journal of Gastroenterology and Hepatology 2007; 22(8): 1190 doi: 10.1111/j.1440-1746.2007.04955.x
|
14 |
John McLaughlin, Lesley A Houghton. The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome. Expert Opinion on Drug Safety 2006; 5(2): 313 doi: 10.1517/14740338.5.2.313
|
15 |
João Vicente Linhares Rodrigues, Luiz C. Bertges, Carolina F.M.G. Pimentel, Priscilla O. Neves, Renata L. Bormann, José Ricci Júnior, Pedro R. Nardelli, Gabriela C. Toledo. TRÂNSITO GASTROINTESTINAL DE Rattus norvegicus (Berkenhout, 1769) (Rodentia:Muridae) APÓS ADMINISTRAÇÃO DE TEGASERODE. GE Jornal Português de Gastrenterologia 2014; 21(4): 138 doi: 10.1016/j.jpg.2014.02.005
|
16 |
Bowen Feng, Yu Wang, Peijing Rong. Central mechanisms of acupuncture in relieving visceral hypersensitivity in functional gastrointestinal disorders: A narrative review. Science of Traditional Chinese Medicine 2023; 1(2): 90 doi: 10.1097/st9.0000000000000016
|
17 |
L. Bueno, F. De Ponti, M. Fried, G. A. Kullak‐ublick, M. A. Kwiatek, D. Pohl, E. M. M. Quigley, J. Tack, N. J. Talley. Serotonergic and non‐serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterology & Motility 2007; 19(s1): 89 doi: 10.1111/j.1365-2982.2006.00876.x
|
18 |
Manoj Shah. Animal Models and Experimental Research in Medicine. 2023; doi: 10.5772/intechopen.106859
|
19 |
Whitney Emerson Steinmetz. Evaluation and management of irritable bowel syndrome. The Nurse Practitioner 2023; 48(8): 30 doi: 10.1097/01.NPR.0000000000000084
|
20 |
Olga A. Lyubashina, Ivan B. Sivachenko, Irina I. Busygina, Sergey S. Panteleev. Colitis-induced alterations in response properties of visceral nociceptive neurons in the rat caudal medulla oblongata and their modulation by 5-HT3 receptor blockade. Brain Research Bulletin 2018; 142: 183 doi: 10.1016/j.brainresbull.2018.07.013
|
21 |
Kristen E. Farrell, Simon Keely, Brett A. Graham, Robin Callister, Robert J. Callister. A Systematic Review of the Evidence for Central Nervous System Plasticity in Animal Models of Inflammatory-mediated Gastrointestinal Pain. Inflammatory Bowel Diseases 2014; 20(1): 176 doi: 10.1097/01.MIB.0000437499.52922.b1
|
22 |
Valentina Noemi Madia, Antonella Messore, Francesco Saccoliti, Valeria Tudino, Alessandro De Leo, Daniela De Vita, Martina Bortolami, Luigi Scipione, Ivano Pindinello, Roberta Costi, Roberto Di Santo. Tegaserod for the Treatment of Irritable Bowel Syndrome. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2020; 19(4): 342 doi: 10.2174/1871523018666190911121306
|